UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?

Breast cancer research : BCR, 2019-04, Vol.21 (1), p.49-49, Article 49

2019

Volltextzugriff (PDF)

Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls

Journal of personalized medicine, 2021-11, Vol.11 (11), p.1211

2021

Volltextzugriff (PDF)

Androgen receptor in breast cancer: The “5W” questions

Frontiers in endocrinology (Lausanne), 2022-08, Vol.13, p.977331-977331

2022

Volltextzugriff (PDF)

T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer

International journal of molecular sciences, 2022-08, Vol.23 (15), p.8590

2022

Volltextzugriff (PDF)

Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients?

Translational oncology, 2022-01, Vol.15 (1), p.101300-101300, Article 101300

2022

Volltextzugriff (PDF)

Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors

Heart (British Cardiac Society), 2013-05, Vol.99 (9), p.634-639

2013

Volltextzugriff (PDF)

Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab

Scientific reports, 2022-03, Vol.12 (1), p.3385-3385, Article 3385

2022

Volltextzugriff (PDF)

Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast Cancer

Cancers, 2020-09, Vol.12 (9), p.2490

2020

Volltextzugriff (PDF)

Circulating Tumor Cells as a Tool to Untangle the Breast Cancer Heterogeneity Issue

Biomedicines, 2021-09, Vol.9 (9), p.1242

2021

Volltextzugriff (PDF)

Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis

Cancers, 2022-08, Vol.14 (16), p.3925

2022

Volltextzugriff (PDF)

Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?

BMC cancer, 2018-03, Vol.18 (1), p.348-348, Article 348

2018

Volltextzugriff (PDF)

Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold

Diagnostic pathology, 2020-09, Vol.15 (1), p.109-109, Article 109

2020

Volltextzugriff (PDF)

An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy

Biomedicines, 2024-02, Vol.12 (3), p.498

2024

Volltextzugriff (PDF)

Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer

Cancers, 2022-09, Vol.14 (18), p.4481

2022

Volltextzugriff (PDF)

Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer

Cell transplantation, 2020-01, Vol.29, p.96368972092505-963689720925057

2020

Volltextzugriff (PDF)

Why the complications of COVID-19 patients differ in elderly and young cancer patients

Translational oncology, 2022-12, Vol.26, p.101541-101541, Article 101541

2022

Volltextzugriff (PDF)

Obesity and Dose of Anti-cancer Therapy: Are We Sure to Be on the Right Track in the Precision Medicine Era?

Frontiers in medicine, 2021-09, Vol.8, p.725346-725346

2021

Volltextzugriff (PDF)

Progress with palbociclib in breast cancer: latest evidence and clinical considerations

Therapeutic Advances in Medical Oncology, 2017-02, Vol.9 (2), p.83-105

2017

Volltextzugriff (PDF)

Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study

Current oncology (Toronto), 2022-01, Vol.29 (2), p.433-438

2022

Volltextzugriff (PDF)

Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?

Translational oncology, 2018-08, Vol.11 (4), p.950-956

2018

Volltextzugriff (PDF)

miR-9-5p as a Regulator of the Androgen Receptor Pathway in Breast Cancer Cell Lines

Frontiers in cell and developmental biology, 2020-11, Vol.8, p.579160-579160

2020

Volltextzugriff (PDF)

Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience

Diagnostics (Basel), 2020-08, Vol.10 (8), p.573

2020

Volltextzugriff (PDF)

What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy?

Breast cancer research and treatment, 2019-08, Vol.177 (1), p.231-232

2019

Volltextzugriff (PDF)

Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast Cancer

Frontiers in molecular biosciences, 2021-11, Vol.8, p.732900-732900

2021

Volltextzugriff (PDF)

The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects

Frontiers in cell and developmental biology, 2021-11, Vol.9, p.772216-772216

2021

Volltextzugriff (PDF)

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(95)
Mit Volltextzugriff
(97)

Publikationsform

Sprache

Englisch
(101)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(73)
Life Sciences & Biomedicine
(71)
Oncology
(44)
Breast Cancer
(43)
Humans
(42)
Female
(37)
Middle Aged
(21)
Adult
(20)
Aged
(19)
Breast Neoplasms - Drug Therapy
(17)
Cancer Therapies
(17)
Metastasis
(17)
Breast Neoplasms - Pathology
(16)
Chemotherapy
(16)
Cancer
(15)
Prognosis
(14)
Tumors
(14)
Medicine
(13)
Treatment Outcome
(13)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

CD68, CD163, and matrix metalloproteinase 9 (MMP-9) in breast tumor microenvironment to predict breast cancer survival: are they enough?

Trop-2 Therapy in Metastatic Triple-Negative Breast Cancer in Italy: Clinical Opportunity and Regulatory Pitfalls

Androgen receptor in breast cancer: The “5W” questions

T-Cell Receptor Repertoire Sequencing and Its Applications: Focus on Infectious Diseases and Cancer

Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients?

Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors

Computed tomography based analyses of body mass composition in HER2 positive metastatic breast cancer patients undergoing first line treatment with pertuzumab and trastuzumab

Single-Cell NGS-Based Analysis of Copy Number Alterations Reveals New Insights in Circulating Tumor Cells Persistence in Early-Stage Breast Cancer

Circulating Tumor Cells as a Tool to Untangle the Breast Cancer Heterogeneity Issue

Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis

Androgen receptor in advanced breast cancer: is it useful to predict the efficacy of anti-estrogen therapy?

Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold

An Italian Real-World Study Highlights the Importance of Some Clinicopathological Characteristics Useful in Identifying Metastatic Breast Cancer Patients Resistant to CDK4/6 Inhibitors and Hormone Therapy

Real-World Outcomes and Treatments Patterns Prior and after the Introduction of First-Line Immunotherapy for the Treatment of Metastatic Non-Small Cell Lung Cancer

Cell-Free DNA Variant Sequencing Using CTC-Depleted Blood for Comprehensive Liquid Biopsy Testing in Metastatic Breast Cancer

Why the complications of COVID-19 patients differ in elderly and young cancer patients

Obesity and Dose of Anti-cancer Therapy: Are We Sure to Be on the Right Track in the Precision Medicine Era?

Progress with palbociclib in breast cancer: latest evidence and clinical considerations

Appropriateness and Economic Analysis of Conventional Circulating Biomarkers Assessment in Early Breast Cancer: A Real-World Experience from the E.Pic.A Study

Androgen Receptor Expression in Breast Cancer: What Differences Between Primary Tumor and Metastases?

miR-9-5p as a Regulator of the Androgen Receptor Pathway in Breast Cancer Cell Lines

Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience

What is the best clinical pathological score to identify high-risk patients with lobular carcinoma of the breast who are likely to benefit from adjuvant chemotherapy?

Early Detection and Investigation of Extracellular Vesicles Biomarkers in Breast Cancer

The Expression of Programmed Death Ligand 1 and Vimentin in Resected Non-Metastatic Non-Small-Cell Lung Cancer: Interplay and Prognostic Effects

Suchergebnisse filtern